Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome
FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome
The U.
FDA spanks KVK Tech over impurities in ADHD drug
FDA spanks KVK Tech over impurities in ADHD drug
The FDA has found issues with the testing practices of a U.
‘Smart watches’ for Alzheimer’s discussed as numbers set to double by 2050
‘Smart watches’ for Alzheimer’s discussed as numbers set to double by 2050
Alzheimer’s Research UK has launched a new global initiative to “revolutionise” the early detection of neurodegenerative diseases like Alzheimer’s.
Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)
Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)
Paris - February 24, 2020 – Sanofi plans to create a major leading European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (API), whi...
Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics
Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics
Feb 24, 2020 Colorado is making a play for a Japanese CDMO in hopes it will invest about $100 million in an empty AstraZeneca plant in Boulder.
Biocon confident of approval for Lantus copy after Malaysia plant inspected by FDA a third time
Biocon confident of approval for Lantus copy after Malaysia plant inspected by FDA a third time
With a new target date fast approaching for its competitor to Lantus, Biocon’s insulin manufacturing plant in Malaysia has again been given a once over by the FDA.
‘Record high’ two million people at type II diabetes risk
‘Record high’ two million people at type II diabetes risk
New NHS figures have revealed that approximately two million people in England are at risk of developing Type II diabetes, the highest on record.
New CRISPR base-editing technology slows ALS progression in mice
New CRISPR base-editing technology slows ALS progression in mice
With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral scleros...
A better diagnosis of rare diabetes to adapt treatment
A better diagnosis of rare diabetes to adapt treatment
Diabetes affects more than 400 million people worldwide and is a major public health problem.
Opdivo/Yervoy continues to impress in kidney cancer
Opdivo/Yervoy continues to impress in kidney cancer
Bristol-Myers Squibb has announced that its Opdivo (nivolumab) and Yervoy (ipilimumab) combo has demonstrated superior overall survival, complete response rates and objective response ...
Teva’s Austedo flunks in late-stage paediatric Tourette study
Teva’s Austedo flunks in late-stage paediatric Tourette study
Teva has announced that Austedo (deutetrabenazine) failed to meet its primary endpoints of reduction in motor and phonic tics in moderate-to-severe paediatric Tourette syndrome.
Audentes Therapeutics Announces Plans to Build New State-of-the-Art Gene Therapy Manufacturing Facility in Sanford, North Carolina
Audentes Therapeutics Announces Plans to Build New State-of-the-Art Gene Therapy Manufacturing Facility in Sanford, North Carolina
SAN FRANCISCO, CA and RALEIGH, N.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand